Clinicopathologic Features of Adult-onset Still's Disease Complicated by Severe Liver Injury

  • Kurokawa Miho
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Hioki Tomonobu
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Aoyagi Tomomi
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Takahashi Motoi
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Imoto Koji
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Goya Takeshi
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Tanaka Masatake
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Kohjima Motoyuki
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan
  • Ogawa Yoshihiro
    Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Japan

Description

<p>Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder. Severe liver injury has rarely been reported, although liver enzyme elevation is a common complication of AOSD. We herein report four cases of relapsed AOSD with severe liver disorder by tapering or terminating corticosteroids. Liver specimens revealed robust infiltration of inflammatory cells throughout the lobule, especially cluster of differentiation (CD) 8-positive cells. Relapsed AOSD was refractory to corticosteroid reintroduction and required immunosuppressants. Severe liver injury with AOSD is pathologically characterized by extensive lobular infiltration of CD8-positive cells, and we should consider additive immunosuppressive agents on corticosteroids for treatment. </p>

Journal

  • Internal Medicine

    Internal Medicine 63 (4), 503-511, 2024-02-15

    The Japanese Society of Internal Medicine

References(31)*help

See more

Details 詳細情報について

Report a problem

Back to top